Guangdong VTR Bio-Tech Co Ltd Strategic Asset Allocation Index
Guangdong VTR Bio-Tech Co Ltd strategic asset allocation index. Guangdong VTR Bio-Tech Co Ltd (300381) has a Strategic Asset Allocation Index of 27.2% as of June 2023. Strategic assets (PP&E of CN¥758.56 Million plus long-term investments of CN¥-) total CN¥758.56 Million, measured against net assets of CN¥2.79 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Guangdong VTR Bio-Tech Co Ltd (300381) tangible net worth to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Guangdong VTR Bio-Tech Co Ltd (2010–2022)
Strategic asset allocation index of Guangdong VTR Bio-Tech Co Ltd from 2010 to 2022. This chart shows how Guangdong VTR Bio-Tech Co Ltd's Strategic Asset Allocation Index has evolved across 13 annual periods from 2010 to 2022. As of June 2023, the index stands at 27.2%, representing strategic assets of CN¥758.56 Million against net assets of CN¥2.79 Billion CNY.
Guangdong VTR Bio-Tech Co Ltd Strategic Asset Allocation Index by Year (2010–2022)
Guangdong VTR Bio-Tech Co Ltd strategic asset allocation index by year from 2010 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Guangdong VTR Bio-Tech Co Ltd from 2010 to 2022, covering 13 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 300381 stock market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 25.2% | CN¥708.22 Million | CN¥708.22 Million | CN¥- | CN¥2.82 Billion | ▼ -27.4 pp |
| 2021 | 52.6% | CN¥1.60 Billion | CN¥1.60 Billion | CN¥- | CN¥3.05 Billion | ▲ +3.2 pp |
| 2020 | 49.3% | CN¥1.61 Billion | CN¥1.61 Billion | CN¥- | CN¥3.26 Billion | ▼ -7.7 pp |
| 2019 | 57.1% | CN¥1.56 Billion | CN¥1.56 Billion | CN¥- | CN¥2.73 Billion | ▲ +1.4 pp |
| 2018 | 55.6% | CN¥1.34 Billion | CN¥1.33 Billion | CN¥6.98 Million | CN¥2.41 Billion | ▼ -1.0 pp |
| 2017 | 56.6% | CN¥1.18 Billion | CN¥1.18 Billion | CN¥3.00 Million | CN¥2.09 Billion | ▲ +9.6 pp |
| 2016 | 47.0% | CN¥965.97 Million | CN¥962.97 Million | CN¥3.00 Million | CN¥2.05 Billion | ▼ -8.9 pp |
| 2015 | 55.9% | CN¥791.12 Million | CN¥788.12 Million | CN¥3.00 Million | CN¥1.42 Billion | ▲ +6.3 pp |
| 2014 | 49.6% | CN¥340.05 Million | CN¥340.05 Million | CN¥- | CN¥685.38 Million | ▼ -8.7 pp |
| 2013 | 58.4% | CN¥178.43 Million | CN¥178.43 Million | CN¥- | CN¥305.76 Million | ▲ +11.2 pp |
| 2012 | 47.1% | CN¥114.37 Million | CN¥114.37 Million | CN¥- | CN¥242.72 Million | ▲ +0.1 pp |
| 2011 | 47.0% | CN¥88.36 Million | CN¥88.36 Million | CN¥- | CN¥188.00 Million | ▼ -10.3 pp |
| 2010 | 57.3% | CN¥83.02 Million | CN¥83.02 Million | CN¥- | CN¥144.81 Million | — |